BCL2L11 and Hepatic fibrosis: Recent studies have found that metformin can improve liver function and hepatic fibrosis induced by NASH by upregulating BIM, BAD and PUMA and downregulating Bcl-2 and Bcl-xL to induce apoptosis in HSCs [43], which provides a new approach for the management of hepatic fibrosis.